| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $6,965,269 ) |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 001 | 2 | NIH | 3/28/2024 | $360,339 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R21HL175170 | Possible transfusion transmitted cerebral amyloid angiopathy: evaluation of transmission of Aβ using the RADAR repository | 000 | 1 | NIH | 8/16/2024 | $118,725 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01AI184421 | Modulation of Galectin-9 to Target HIV Persistence | 000 | 1 | NIH | 7/31/2024 | $775,391 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01AI168322 | Hematopoietic and Immune Development in the Human Chorion | 000 | 3 | NIH | 3/13/2024 | $596,144 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01AI168322 | Hematopoietic and Immune Development in the Human Chorion | 001 | 3 | NIH | 5/23/2024 | $66,239 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R21HL175170 | Possible transfusion transmitted cerebral amyloid angiopathy: evaluation of transmission of Aβ using the RADAR repository | 001 | 1 | NIH | 8/20/2024 | $12,525 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | U01IP001266 | RFA-IP-24-046: Nationwide Cohort of Blood Donors to Estimate Burden of Respiratory Viruses and Immunologic Response | 00 | 1 | CDC | 8/29/2024 | $1,600,000 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | U01IP001266 | RFA-IP-24-046: Nationwide Cohort of Blood Donors to Estimate Burden of Respiratory Viruses and Immunologic Response | 00 | 1 | CDC | 8/29/2024 | $2,900,000 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | DP1HL174193 | Extracellular Vesicles as Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Disease in Persons Living with HIV | 001 | 1 | NIH | 6/19/2024 | $41,395 |
| | 2024 | 2024 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | DP1HL174193 | Extracellular Vesicles as Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Disease in Persons Living with HIV | 000 | 1 | NIH | 5/30/2024 | $494,511 |
| | 2024 | 2023 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R56HL134653 | Effect of blood donor sex and inter-individual variability in plasma testosterone on the transfusion effectiveness and hemostatic potential of red blood cells and platelets | 001 | 7 | NIH | 3/4/2024 | $142,998 |
| | 2024 | 2023 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R56HL134653 | Effect of blood donor sex and inter-individual variability in plasma testosterone on the transfusion effectiveness and hemostatic potential of red blood cells and platelets | 000 | 7 | NIH | 1/30/2024 | $0 |
| | 2024 | 2023 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 000 | 1 | NIH | 1/23/2024 | $121,519 |
| | 2024 | 2022 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R56AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 000 | 1 | NIH | 1/23/2024 | -$121,519 |
| | 2024 | 2022 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01HL134653 | Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cells | 000 | 6 | NIH | 3/4/2024 | -$142,998 |
|
| Issue Date FY: 2023 ( Subtotal = $2,315,796 ) |
| | 2023 | 2023 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 000 | 1 | NIH | 3/27/2023 | $290,874 |
| | 2023 | 2023 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 001 | 1 | NIH | 6/2/2023 | -$290,874 |
| | 2023 | 2023 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 001 | 1 | NIH | 6/2/2023 | $290,874 |
| | 2023 | 2023 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 002 | 1 | NIH | 6/14/2023 | $290,874 |
| | 2023 | 2023 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 002 | 1 | NIH | 6/14/2023 | -$290,874 |
| | 2023 | 2023 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R56HL134653 | Effect of blood donor sex and inter-individual variability in plasma testosterone on the transfusion effectiveness and hemostatic potential of red blood cells and platelets | 000 | 7 | NIH | 9/24/2023 | $739,483 |
| | 2023 | 2023 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI168322 | Hematopoietic and Immune Development in the Human Chorion | 000 | 2 | NIH | 3/29/2023 | $662,383 |
| | 2023 | 2023 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL153073 | Transfusion-related immunomodulation influences infectious disease outcomes | 000 | 4 | NIH | 8/2/2023 | $623,056 |
| | 2023 | 2022 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R56AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 001 | 1 | NIH | 3/17/2023 | $0 |
| | 2023 | 2022 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R56AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 000 | 1 | NIH | 10/31/2022 | $0 |
| | 2023 | 2022 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01HL134653 | Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cells | 000 | 6 | NIH | 9/23/2023 | $0 |
| | 2023 | 2020 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01MH112457 | Effects of Human Galectin-9 on the CNS HIV Reservoir | 000 | 5 | NIH | 7/20/2023 | $0 |
| | 2023 | 2019 | VITALANT | 9305 E VIA DE VENTURA | SCOTTSDALE | AZ | 85258-3597 | MARICOPA | USA | R01AI150449 | Effects of Cell-Intrinsic Immunity on Establishment and Reversal of HIV Latency | 000 | 5 | NIH | 11/21/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $2,446,259 ) |
| | 2022 | 2022 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL144501 | The impact of illness and medical treatments on the alloantibody response to platelet transfusion | 000 | 4 | NIH | 6/3/2022 | $741,513 |
| | 2022 | 2022 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI168322 | Hematopoietic and Immune Development in the Human Chorion | 000 | 1 | NIH | 4/11/2022 | $676,958 |
| | 2022 | 2022 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R56AI172754 | Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | 000 | 1 | NIH | 8/23/2022 | $277,025 |
| | 2022 | 2022 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL153073 | Transfusion-related immunomodulation influences infectious disease outcomes | 000 | 3 | NIH | 6/3/2022 | $615,838 |
| | 2022 | 2022 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL134653 | Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cells | 001 | 6 | NIH | 7/1/2022 | $38,523 |
| | 2022 | 2022 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL134653 | Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cells | 000 | 6 | NIH | 12/31/2021 | $346,699 |
| | 2022 | 2019 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI119056 | Protective B-cell responses in chikungunya virus infection | 000 | 4 | NIH | 10/14/2021 | -$68,112 |
| | 2022 | 2019 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI150449 | Effects of Cell-Intrinsic Immunity on Establishment and Reversal of HIV Latency | 000 | 5 | NIH | 4/4/2022 | -$301 |
| | 2022 | 2019 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01AI123376 | Viral etiology of idiopathic chronic diarrhea in rhesus macaques | 000 | 4 | NIH | 4/4/2022 | -$181,884 |
|
| Issue Date FY: 2021 ( Subtotal = $1,423,559 ) |
| | 2021 | 2021 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL153073 | Transfusion-related immunomodulation influences infectious disease outcomes | 000 | 2 | NIH | 6/28/2021 | $612,357 |
| | 2021 | 2021 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL144501 | The impact of illness and medical treatments on the alloantibody response to platelet transfusion | 000 | 3 | NIH | 6/25/2021 | $760,351 |
| | 2021 | 2021 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL134653 | Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cells | 000 | 5 | NIH | 12/31/2020 | $346,722 |
| | 2021 | 2018 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R21HL137439 | Clinical Outcomes of Zika Virus in Sickle Cell Disease | 001 | 2 | NIH | 6/25/2021 | -$114,785 |
| | 2021 | 2018 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL133024 | Mechanisms regulating alloimmunization and tolerance with pathogen reduction and transfusion of allogeneic platelets | 000 | 3 | NIH | 11/16/2020 | -$2,432 |
| | 2021 | 2017 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R21HL137439 | Clinical Outcomes of Zika Virus in Sickle Cell Disease | 000 | 1 | NIH | 6/25/2021 | -$178,654 |
|
| Issue Date FY: 2020 ( Subtotal = $2,145,373 ) (Continued on the next page) |
| | 2020 | 2020 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL153073 | Transfusion-related immunomodulation influences infectious disease outcomes | 000 | 1 | NIH | 8/28/2020 | $604,784 |
| | 2020 | 2020 | VITALANT | 6210 E OAK ST | SCOTTSDALE | AZ | 85257-1101 | MARICOPA | USA | R01HL134653 | Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cells | 000 | 4 | NIH | 12/20/2019 | $366,006 |
|
